Showing results (221-230 of 292) with videos related to
Sort By:
Pageof 30
Expert Review of Pharmacoeconomics & Outcomes Research|September 2, 2024
Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriersMaximillian Otte, Hans Peter Dauben, Jeonghoon Ahn, et al.Pharmaceuticals (Basel, Switzerland)|October 24, 2020
Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in GermanyEvelien Moorkens, Teresa Barcina Lacosta, Arnold G Vulto, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 23, 2010
The costs of breast cancer prior to and following diagnosisSteven Broekx, Elly Den Hond, Rudi Torfs, et al.Journal of Palliative Medicine|November 3, 2010
Costs of terminal patients who receive palliative care or usual care in different hospital wardsSteven Simoens, Betty Kutten, Emmanuel Keirse, et al.Vaccines|November 25, 2023
Reply to Standaert, B. Comment on "Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium"Maarten J Postma, Chih-Yuan Cheng, Nasuh C Buyukkaramikli, et al.Vaccines|May 27, 2023
Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in BelgiumMaarten J Postma, Chih-Yuan Cheng, Nasuh C Buyukkaramikli, et al.Frontiers in Medicine|October 27, 2018
Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and PracticeRosanne Janssens, Eline van Overbeeke, Lotte Verswijvel, et al.BMC Medical Informatics and Decision Making|February 13, 2019
Development and implementation of "Check of Medication Appropriateness" (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillanceCharlotte Quintens, Thomas De Rijdt, Tine Van Nieuwenhuyse, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 12, 2021
Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader PerspectiveLieven Annemans, Philippe Beutels, David E Bloom, et al.Bone|October 7, 2008
Body composition, volumetric and areal bone parameters in male-to-female transsexual personsBruno Lapauw, Youri Taes, Steven Simoens, et al.Pageof 30